InvestorsHub Logo
Followers 239
Posts 12005
Boards Moderated 0
Alias Born 08/14/2003

Re: savagess post# 388

Sunday, 07/26/2020 12:55:57 AM

Sunday, July 26, 2020 12:55:57 AM

Post# of 448
You're no doubt right, it's the way all sort of companies operate when they don't have earnings. Dilution or a partnership are the only way out until they have a product approved for sale. I see that Nabriva does have one product approved, but I'm uncertain about sales, it sounds like they're looking to partner. Such a partnership would probably resolve all their problems.

I really don't know that much about the company, took a small position at the recommendation of a friend. If the R/S is approved, I don't know that I'll stay with it. If I remember correctly, the approval of a second drug is anticipated, but being held up by the FDA's inability to approve the production facility located outside the U.S. To my way of thinking if that's all that's holding it back, any idea why they've not gone for European approval. That could lead to the higher prices, perhaps a partnership, and I'd hope the FDA would agree to the European approval of the production facilities if it's an approved drug that they've approved the production facility for.

Gary